Cargando…

Exendin-4 Treatment Improves LPS-Induced Depressive-Like Behavior Without Affecting Pro-Inflammatory Cytokines

Background: Exendin-4 is a peptide agonist of the glucagon-like peptide-1 (GLP-1) receptor, currently in clinical trials as a potential disease-modifying therapy for Parkinson’s disease. In light of this, it is important to understand potential modes of action of exendin-4 in the brain. Exendin-4 is...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ventorp, Filip, Bay-Richter, Cecilie, Nagendra, Analise Sauro, Janelidze, Shorena, Matsson, Viktor Sjödahl, Lipton, Jack, Nordström, Ulrika, Westrin, Åsa, Brundin, Patrik, Brundin, Lena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2017
Materias:	Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438473/ https://www.ncbi.nlm.nih.gov/pubmed/28387682 http://dx.doi.org/10.3233/JPD-171068

Ejemplares similares

Behavioural and neurobiological consequences of macrophage migration inhibitory factor gene deletion in mice
por: Bay-Richter, Cecilie, et al.
Publicado: (2015)

Pro-Inflammatory Cytokines Reduce the Proliferation of NG2 Cells and Increase Shedding of NG2 In Vivo and In Vitro
por: Wennström, Malin, et al.
Publicado: (2014)

Six autoantibodies associated with autoimmune encephalitis are not detectable in the cerebrospinal fluid of suicide attempters
por: Fernström, Johan, et al.
Publicado: (2017)

Increased Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels in Plasma of Suicide Attempters
por: Ventorp, Filip, et al.
Publicado: (2015)

Effects of Acute Exercise on Circulating Soluble Form of the Urokinase Receptor in Patients With Major Depressive Disorder
por: Gustafsson, Anna, et al.
Publicado: (2017)

Decreased Risk of Parkinson’s Disease After Rheumatoid Arthritis Diagnosis: A Nested Case-Control Study with Matched Cases and Controls
por: Bacelis, Jonas, et al.
Publicado: (2021)

Introduction
por: Patrik, Brundin
Publicado: (2017)

Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
por: Thirtamara-Rajamani, Keerthi, et al.
Publicado: (2017)

Enrichment of risk SNPs in regulatory regions implicate diverse tissues in Parkinson’s disease etiology
por: Coetzee, Simon G., et al.
Publicado: (2016)

Editorial: Targeting α-Synuclein in Parkinson's Disease and Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2022)

Connecting inflammation with glutamate agonism in suicidality
por: Erhardt, Sophie, et al.
Publicado: (2013)

Identification of Multiple QTLs Linked to Neuropathology in the Engrailed-1 Heterozygous Mouse Model of Parkinson’s Disease
por: Kurowska, Zuzanna, et al.
Publicado: (2016)

Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
por: George, Sonia, et al.
Publicado: (2015)

Immunological aspects of grafting in the mammalian central nervous system. A review and speculative synthesis
por: Widner, Håkan, et al.
Publicado: (1988)

Asialoerythropoetin is not effective in the R6/2 line of Huntington's disease mice
por: Gil, Joana MAC, et al.
Publicado: (2004)

25(OH)D levels are decreased in patients with difficult-to-treat depression
por: Grudet, C., et al.
Publicado: (2022)

The Times They Are a-Changin’: Parkinson’s Disease 20 Years from Now
por: Brundin, Patrik, et al.
Publicado: (2018)

Parkinson’s Disease: We Care!
por: Bloem, Bastiaan R., et al.
Publicado: (2020)

Leaky gut biomarkers in depression and suicidal behavior
por: Ohlsson, L., et al.
Publicado: (2018)

Targeted Therapies for Parkinson's Disease: From Genetics to the Clinic
por: Sardi, S. Pablo, et al.
Publicado: (2018)

Is COVID-19 a Perfect Storm for Parkinson’s Disease?
por: Brundin, Patrik, et al.
Publicado: (2020)

What’s to like about the prion-like hypothesis for the spreading of aggregated α-synuclein in Parkinson disease?
por: Dunning, Christopher J.R., et al.
Publicado: (2013)

Nilotinib – Differentiating the Hope from the Hype
por: Wyse, Richard K., et al.
Publicado: (2016)

The olfactory bulb as the entry site for prion-like propagation in neurodegenerative diseases
por: Rey, Nolwen L., et al.
Publicado: (2016)

Precision medicine in Parkinson’s disease patients with LRRK2 and GBA risk variants – Let’s get even more personal
por: von Linstow, Christian U., et al.
Publicado: (2020)

Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation
por: Mezias, Christopher, et al.
Publicado: (2019)

Oxidative stress in neurodegenerative disease: causation or association?
por: Van Raamsdonk, Jeremy M., et al.
Publicado: (2017)

Drug Repurposing for Parkinson’s Disease: The International Linked Clinical Trials experience
por: Stott, Simon R. W., et al.
Publicado: (2021)

An Efficient Procedure for Removal and Inactivation of Alpha-Synuclein Assemblies from Laboratory Materials
por: Bousset, Luc, et al.
Publicado: (2016)

Endogenous alpha-synuclein monomers, oligomers and resulting pathology: let’s talk about the lipids in the room
por: Killinger, Bryan A., et al.
Publicado: (2019)

Editorial: Protein Misfolding and Spreading Pathology in Neurodegenerative Diseases
por: Lázaro, Diana F., et al.
Publicado: (2020)

Linking α-synuclein-induced synaptopathy and neural network dysfunction in early Parkinson’s disease
por: Kulkarni, Aishwarya S, et al.
Publicado: (2022)

Role of Inflammation in Suicide: From Mechanisms to Treatment
por: Brundin, Lena, et al.
Publicado: (2017)

Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
por: Heilman, Patrick L., et al.
Publicado: (2020)

Direct targeting of wild-type glucocerebrosidase by antipsychotic quetiapine improves pathogenic phenotypes in Parkinson’s disease models
por: Burbulla, Lena F., et al.
Publicado: (2021)

Growth Factors and Feeder Cells Promote Differentiation of Human Embryonic Stem Cells into Dopaminergic Neurons: A Novel Role for Fibroblast Growth Factor-20
por: Correia, Ana Sofia, et al.
Publicado: (2008)

Exendin-4 for Parkinson's disease
por: Esparza-Salazar, Felipe de Jesús, et al.
Publicado: (2021)

Microglia affect α-synuclein cell-to-cell transfer in a mouse model of Parkinson’s disease
por: George, Sonia, et al.
Publicado: (2019)

Plant Polyphenols and Exendin-4 Prevent Hyperactivity and TNF-α Release in LPS-Treated In vitro Neuron/Astrocyte/Microglial Networks
por: Gullo, Francesca, et al.
Publicado: (2017)

"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells
por: Anisimov, Sergey V, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_in922k13e0cps0e6b11oq2hl20